High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors
New England Journal of Medicine2007Vol. 357(4), pp. 340–348
Citations Over TimeTop 1% of 2007 papers
Lawrence H. Einhorn, Stephen D. Williams, Amy R. Chamness, Mary J. Brames, Susan M. Perkins, Rafat Abonour
Abstract
Testicular tumors are potentially curable by means of high-dose chemotherapy plus hematopoietic stem-cell rescue, even when this regimen is used as third-line or later therapy or in patients with platinum-refractory disease.
Related Papers
- → The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors(1990)121 cited
- → Effects of multiple-drug chemotherapy (cis-diammine-dichloroplatinum, bleomycin, and vinblastine) on the maturation of retroperitoneal lymph node metastases of nonseminomatous germ cell tumors of the testis: No evidence for de novo induction of differentiation(1983)98 cited
- Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine, and bleomycin.(1982)
- Inclusion of cisplatinum (cis-DDP, Platidiam, Lachema) into combined chemotherapeutic protocol for the treatment of testicular cancer.(1983)
- → Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer(2021)